Samsung Bioepis Expands SB15 Eylea Rival: Licensing Pact Targets Global Markets as Original Drug Hits $10.5B Sales

Courtesy of Samsung Bioepis
Courtesy of Samsung Bioepis

© Copyright by News1. All Rights Reserved.